Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 
RMJ. 2021; 46(2): 318-322


Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease

Amara Gul, Javed Yousaf.

Abstract
Objective: To examine executive functioning and cognitive inhibition as coexisting factors of behavioral inhibition among patients having Parkinsonís disease.
Methodology: Fifty individuals with a diagnosis of Parkinsonís disease at Recep Tayyip Erdogan Hospital, Bahawal Victoria Hospital and Nishter Hospital during April 2016 to March 2017 and fifty healthy individuals participated in the study. Participants completed Behavioral Inhibition and Activation Questionnaire, The Executive Interview 25, and Trail Making Test-part B.
Results: Patients with Parkinsonís disease showed impaired executive functioning, behavioral and cognitive inhibition in contrast with healthy individuals. Behavioral disinhibiting correlated with impaired cognitive inhibition and executive functioning in patients with Parkinsonís disease. Executive functioning was significant coexisting factor of behavioral inhibition.
Conclusion: Executive functioning is a significant coexisting factor of behavioral inhibition in Parkinsonís disease with cognitive inhibition.

Key words: Parkinson, executive functions, cognition.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Amara Gul
Articles by Javed Yousaf
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Gul A, Yousaf J. Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. RMJ. 2021; 46(2): 318-322.


Web Style

Gul A, Yousaf J. Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. http://www.rmj.org.pk/?mno=298992 [Access: June 12, 2021].


AMA (American Medical Association) Style

Gul A, Yousaf J. Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. RMJ. 2021; 46(2): 318-322.



Vancouver/ICMJE Style

Gul A, Yousaf J. Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. RMJ. (2021), [cited June 12, 2021]; 46(2): 318-322.



Harvard Style

Gul, A. & Yousaf, . J. (2021) Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. RMJ, 46 (2), 318-322.



Turabian Style

Gul, Amara, and Javed Yousaf. 2021. Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. Rawal Medical Journal, 46 (2), 318-322.



Chicago Style

Gul, Amara, and Javed Yousaf. "Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease." Rawal Medical Journal 46 (2021), 318-322.



MLA (The Modern Language Association) Style

Gul, Amara, and Javed Yousaf. "Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease." Rawal Medical Journal 46.2 (2021), 318-322. Print.



APA (American Psychological Association) Style

Gul, A. & Yousaf, . J. (2021) Executive functioning and cognitive inhibition: comorbid-predictors of behavioral inhibition in the early course of Parkinsonís disease. Rawal Medical Journal, 46 (2), 318-322.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED,  Scopus and Web of Science

                     Approved by the Higher Education Commission of Pakistan 


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.